Skip to main content
letter
. 2020 Nov 5;197:65–68. doi: 10.1016/j.thromres.2020.10.031

Table 1.

Baseline characteristics by anticoagulation status.

Prophylactic AC (N = 250) Therapeutic AC (N = 152) Total (N = 402) p value
Sex 0.54a
 Female 120 (47.4%) 66 (44.3%) 186 (46.3%)
 Male 133 (52.6%) 83 (55.7%) 216 (53.7%)
Age 0.01b
 <30 12 (4.7%) 4 (2.7%) 16 (4.0%)
 30–39 25 (9.9%) 7 (4.7%) 32 (8.0%)
 40–49 32 (12.6%) 15 (10.1%) 47 (11.7%)
 50–59 48 (19.0%) 29 (19.5%) 77 (19.2%)
 60–69 58 (22.9%) 35 (23.5%) 93 (23.1%)
 70–79 43 (17.0%) 31 (20.8%) 74 (18.4%)
 >80 35 (13.8%) 28 (18.8%) 63 (15.7%)
African American 0.96a
 No 77 (30.4%) 45 (30.2%) 122 (30.3%)
 Yes 176 (69.6%) 104 (69.8%) 280 (69.7%)
White 0.68a
 No 235 (92.9%) 140 (94.0%) 375 (93.3%)
 Yes 18 (7.1%) 9 (6.0%) 27 (6.7%)
Hispanic 0.88a
 No 216 (85.4%) 128 (85.9%) 344 (85.6%)
 Yes 37 (14.6%) 21 (14.1%) 58 (14.4%)
BMI over 30 0.45a
 No 11 (4.3%) 9 (6.0%) 20 (5.0%)
 Yes 242 (95.7%) 140 (94.0%) 382 (95.0%)
ICU admission <0.01a
 No 214 (84.6%) 80 (53.7%) 294 (73.1%)
 Yes 39 (15.4%) 69 (46.3%) 108 (26.9%)
Intubation <0.01a
 No 230 (90.9%) 109 (73.2%) 339 (84.3%)
 Yes 23 (9.1%) 40 (26.8%) 63 (15.7%)
Chronic pulmonary disease 0.69a
 Missing 8 0 8
 No 182 (74.3%) 108 (72.5%) 290 (73.6%)
 Yes 63 (25.7%) 41 (27.5%) 104 (26.4%)
Cancer 0.37a
 Missing 8 0 8
 No 232 (94.7%) 144 (96.6%) 376 (95.4%)
 Yes 13 (5.3%) 5 (3.4%) 18 (4.6%)
Cardiovascular disease <0.01a
 No 157 (62.1%) 65 (43.6%) 222 (55.2%)
 Yes 96 (37.9%) 84 (56.4%) 180 (44.8%)
Hypertension 0.71a
 No 77 (30.4%) 48 (32.2%) 125 (31.1%)
 Yes 176 (69.6%) 101 (67.8%) 277 (68.9%)
Diabetes 0.53a
 No 144 (56.9%) 80 (53.7%) 224 (55.7%)
 Yes 109 (43.1%) 69 (46.3%) 178 (44.3%)
a

Pearson's Chi-squared test.

b

Trend test for ordinal variables.